Andrej Jedinak Selected Research

ganodermanontriol

11/2011	Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA.
3/2011	Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrej Jedinak Research Topics

Disease

12	Neoplasms (Cancer) 01/2020 - 12/2008
4	Inflammation (Inflammations) 01/2012 - 11/2010
3	Prostatic Neoplasms (Prostate Cancer) 08/2018 - 02/2012
3	Breast Neoplasms (Breast Cancer) 01/2012 - 06/2011
3	Colonic Neoplasms (Colon Cancer) 03/2011 - 01/2010
2	Neoplasm Metastasis (Metastasis) 07/2015 - 06/2014
2	Hyperplasia 04/2015 - 01/2012
2	Carcinogenesis 01/2012 - 11/2010
1	Lung Neoplasms (Lung Cancer) 06/2014
1	Aberrant Crypt Foci 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 03/2011
1	Retinoblastoma (Glioblastoma, Retinal) 12/2008

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2015
4	Proteins (Proteins, Gene)FDA Link 08/2018 - 01/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 03/2010
2	Dextrans (Dextran)FDA Link 01/2012 - 11/2010
2	benzocycloheptapyridineIBA 01/2012 - 11/2010
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2012 - 11/2010
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2012 - 11/2010
2	ganodermanontriolIBA 11/2011 - 03/2011
2	TriterpenesIBA 03/2011 - 01/2010
2	Cyclin D1IBA 03/2011 - 11/2010
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	EnzymesIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 08/2018
1	ProteomeIBA 07/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2014
1	Hematoxylin (Haematoxylon)IBA 06/2014
1	Therapeutic UsesIBA 02/2012
1	GossypolIBA 02/2012
1	Cell Cycle ProteinsIBA 02/2012
1	CarcinogensIBA 01/2012
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2012
1	glycerol dialkyl nonitol tetraethyl etherIBA 11/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 06/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2011
1	lanostanoidIBA 03/2011
1	CateninsIBA 03/2011
1	EndonucleasesIBA 02/2011
1	NF-kappa B (NF-kB)IBA 03/2010
1	Transcription Factors (Transcription Factor)IBA 03/2010
1	Interleukin-6 (Interleukin 6)IBA 03/2010
1	Conditioned Culture MediaIBA 03/2010
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	MitogensIBA 01/2010
1	Phosphotransferases (Kinase)IBA 01/2010
1	Beclin-1IBA 01/2010
1	4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA 01/2010
1	p38 Mitogen-Activated Protein KinasesIBA 01/2010
1	Cyclin-Dependent Kinase Inhibitor p21IBA 12/2008
1	Retinoblastoma ProteinIBA 12/2008

Therapy/Procedure

3	Therapeutics 07/2015 - 11/2011
1	Oral Administration 06/2014
1	Intraperitoneal Injections 05/2011